Disparities in management guidelines for gastrointestinal stromal tumors: A comparison of recommendations from the Chinese Society of Clinical Oncology, National Comprehensive Cancer Network, and European Society for Medical Oncology

Documenti analoghi

• Updates on research and management of gastrointestinal stromal tumors in China
  di: Xinhua Zhang, et al.
  Pubblicazione: (2025)
• Chinese expert consensus on diagnosis and treatment of small gastrointestinal stromal tumors (2025 edition)
  di: Zhidong Gao, et al.
  Pubblicazione: (2025)
• Addressing socioeconomic barriers in the implementation of American Society of Clinical Oncology palliative care guidelines
  di: Raffaele Giusti, et al.
  Pubblicazione: (2025)
• Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition
  di: Hideaki Bando, et al.
  Pubblicazione: (2024)
• Long‐term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial
  di: Jun Zhang, et al.
  Pubblicazione: (2025)